Triple
T1143218
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | European Medicines Agency |
E23502
|
entity |
| Predicate | hasCommittee |
P1396
|
FINISHED |
| Object | Committee for Advanced Therapies |
E23508
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Committee for Advanced Therapies | Statement: [European Medicines Agency, hasCommittee, Committee for Advanced Therapies]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Committee for Advanced Therapies Context triple: [European Medicines Agency, hasCommittee, Committee for Advanced Therapies]
-
A.
Committee for Advanced Therapies
chosen
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
B.
Committee for Orphan Medicinal Products
The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
-
C.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
D.
Banting Research Foundation
The Banting Research Foundation is a Canadian organization that funds early-career health and biomedical researchers, established to honor and continue the scientific legacy of insulin co-discoverer Sir Frederick Banting.
-
E.
Cambridge Stem Cell Institute
The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a493ef399c8190b04b9146d2314f59 |
completed | March 1, 2026, 7:30 p.m. |
| NER | Named-entity recognition | batch_69a4bc4e93d48190b9fea886bf61aad7 |
completed | March 1, 2026, 10:23 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ac59b2395c81909d4608bdaf1d57e8 |
completed | March 7, 2026, 5 p.m. |
Created at: March 1, 2026, 7:44 p.m.